DNA Tests For Psychiatric Drugs Are Controversial But Some Insurers Are Covering Them G Dangor, NPR, October 17, 2019

Main|Search|PHGKB




Last Posted: Oct 18, 2019

---

• DNA Tests For Psychiatric Drugs Are Controversial But Some Insurers Are Covering Them
  G Dangor, NPR, October 17, 2019
• Integrating pharmacogenomics into the electronic health record by implementing genomic indicators.
  Caraballo Pedro J et al. Journal of the American Medical Informatics Association : JAMIA 2019 Oct
• Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases.
  Zhu Ye et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Oct
• A pediatric perspective on genomics and prevention in the twenty-first century.
  Chaudhari Bimal P et al. Pediatric research 2019 Oct
• A stepwise approach to implementing pharmacogenetic testing in the primary care setting.
  Weitzel Kristin Wiisanen et al. Pharmacogenomics 2019 Oct 20(15) 1103-1112
• Pharmacogenetics and the treatment of epilepsy: what do we know?
  Božina Nada et al. Pharmacogenomics 2019 Oct 20(15) 1093-1101
• Pharmacogenomics: Prescribing Precisely.
  Wake Dyson T et al. The Medical clinics of North America 2019 Nov 103(6) 977-990
• Southeast Asian Pharmacogenomics Research Network (SEAPharm): Current Status and Perspectives.
  Chumnumwat Supatat et al. Public health genomics 2019 Oct 1-8
• Towards precision medicine: interrogating the human genome to identify drug pathways associated with potentially functional, population-differentiated polymorphisms
  M Bachtiar et al, The Pharmacogenomics Journal, October 3, 2019
• Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications.
  Kaliyaperumal Kalaiyarasi et al. Journal of hepatology 2018 Oct 69(4) 948-957

more